WO2025141608 - STABLE VANCOMYCIN SOLUTIONS

National phase entry is expected:
Publication Number WO/2025/141608
Publication Date 03.07.2025
International Application No. PCT/IN2024/052431
International Filing Date 26.12.2024
Title **
[English] STABLE VANCOMYCIN SOLUTIONS
[French] SOLUTIONS STABLES DE VANCOMYCINE
Applicants **
EXTROVIS AG
EXTROVIS PRIVATE LIMITED
Inventors
KAMMA, Hanumantha Rao
SINGAMPALLI, Rajasekhara Reddy
BEERAKA, Nagamalleswara Rao
Priority Data
202341090103   30.12.2023   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1956
EPO Filing, Examination, Granting11576
Japan Filing, Examination, Granting1908
South Korea Filing, Examination, Granting1606
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 21,786
Contact Us
Abstract[English] The present disclosure relates to stable aqueous solutions of vancomycin or its pharmaceutically acceptable salt, that are ready to administer to the patient, and those that can be diluted with a suitable diluent, prior to administration.[French] La présente divulgation concerne des solutions aqueuses stables de vancomycine ou de son sel pharmaceutiquement acceptable qui sont prêtes à être administrées au patient, ainsi que celles qui peuvent être diluées avec un diluant approprié avant administration.